Tilray Brands (TLRY) Shareholder's Equity (2017 - 2026)
Tilray Brands (TLRY) Shareholder's Equity (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 1.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.53 Bn |
| Nov 30, 2025 | 1.55 Bn |
| Aug 31, 2025 | 1.52 Bn |
| May 31, 2025 | 1.49 Bn |
| Feb 28, 2025 | 2.70 Bn |
| Nov 30, 2024 | 3.45 Bn |
| Aug 31, 2024 | 3.48 Bn |
| May 31, 2024 | 3.44 Bn |
| Feb 29, 2024 | 3.34 Bn |
| Nov 30, 2023 | 3.39 Bn |
| Aug 31, 2023 | 3.40 Bn |
| May 31, 2023 | 3.33 Bn |
| Feb 28, 2023 | 3.41 Bn |
| Nov 30, 2022 | 4.48 Bn |
| Aug 31, 2022 | 4.56 Bn |
| May 31, 2022 | 4.44 Bn |
| Feb 28, 2022 | 4.66 Bn |
| Nov 30, 2021 | 4.47 Bn |
| Aug 31, 2021 | 4.39 Bn |
| May 31, 2021 | 4.47 Bn |